The Cooper Companies, Inc. (COO) Earnings Call Analysis

NASDAQ · Healthcare · Medical Instruments & Supplies

19/25

Growth 4 Margin 5 Expansion 4 Platform 1 Financial 5

latest quarter score

Earnings Reports

19
CooperCompanies (COO) Q3 2026: 66% Gross Margin Highlights Operational Discipline Amid Channel Inventory Reset
September 11, 2026
20
Cooper Companies (COO) Q2 2026: Surgical Division Attracts Multiple Bids as $272M Litigation Charge Resolved
June 05, 2026
24
Cooper Companies (COO) Q1 2026: Operating Margin Surges to 26.9% as AI and Reorg Drive Efficiency
March 06, 2026
21
CooperCompanies (COO) Q4 2025: MyDay Private Label Surge Drives 5% Vision Growth as Strategic Review Advances
December 05, 2025
22
Cooper Companies (COO) Q3 2025: MyDay Fitting Sets Surge 50%, Positioning for Daily SiHy Share Rebound
August 28, 2025
25
Cooper Companies (COO) Q2 2025: MyDay, Myopia, and Surgical Devices Propel 7% Organic Growth Despite Fertility Slowdown
July 03, 2025
CooperCompanies (COO) Q1 2025: 6% Organic Growth at CooperVision Signals Strong Operational Momentum
March 06, 2025

Browse all companies